Polyphenols, inhibit amyloid‐beta (Aβ) aggregation and tau hyperphosphorylation, hallmarks of AD pathology (Kabir et al. 2023), while modulating neuroinflammation by attenuating microglial and astrocytic activation (Tayab et al. 2022). This evidence concerns the gene MAPT and Alzheimer disease.